Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2025-12-24 @ 11:40 PM
NCT ID:
NCT04113551
Eligibility Criteria:
Inclusion Criteria:
* Participants have been in the database for greater than or equal to (\>=) 30 days
* Have received, between 1 January, 2013 and 30 September, 2018, a prescription for Concerta, Ritalin, Atomoxetine (ATO) or Guanfacine (GFC)
Exclusion Criteria:
\- Participants who received an unspecified Methylphenidate (MPH) formulation
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT04113551
Study Brief:
Protocol Section:
NCT04113551